Pharmaceutical Activation of Nrf2 Accelerates Diabetic Wound Healing by Exosomes from Bone Marrow Mesenchymal Stem Cells

BACKGROUND AND OBJECTIVES: Despite advances in wound treatments, chronic diabetic wounds remain a significant medical challenge. Exosomes from mesenchymal stem cells (MSCs) and small molecule activators of nuclear factor erythroid 2–related factor 2 (Nrf2) have emerged as potential therapies for non...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Cai, Yuhui, Zhang, Qingrong, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148840/
https://www.ncbi.nlm.nih.gov/pubmed/34711700
http://dx.doi.org/10.15283/ijsc21067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148840/
https://www.ncbi.nlm.nih.gov/pubmed/34711700
http://dx.doi.org/10.15283/ijsc21067

Ejemplares similares